Literature DB >> 27663180

Clinical Predictors of Hospital Mortality Differ Between Direct and Indirect ARDS.

Liang Luo1, Ciara M Shaver2, Zhiguo Zhao3, Tatsuki Koyama3, Carolyn S Calfee4, Julie A Bastarache5, Lorraine B Ware6.   

Abstract

BACKGROUND: Direct (pulmonary) and indirect (extrapulmonary) ARDS are distinct syndromes with important pathophysiologic differences. The goal of this study was to determine whether clinical characteristics and predictors of mortality differ between direct or indirect ARDS.
METHODS: This retrospective observational cohort study included 417 patients with ARDS. Each patient was classified as having direct (pneumonia or aspiration, n = 250) or indirect (nonpulmonary sepsis or pancreatitis, n = 167) ARDS.
RESULTS: Patients with direct ARDS had higher lung injury scores (3.0 vs 2.8; P < .001), lower Simplified Acute Physiology Score II scores (51 vs 62; P < .001), lower Acute Physiology and Chronic Health Evaluation II scores (27 vs 30; P < .001), and fewer nonpulmonary organ failures (1 vs 2; P < .001) compared with patients with indirect ARDS. Hospital mortality was similar (28% vs 31%). In patients with direct ARDS, age (OR, 1.29 per 10 years; P = .01; test for interaction, P = .03), lung injury scores (OR, 2.29 per point; P = .001; test for interaction, P = .058), and number of nonpulmonary organ failures (OR, 1.67; P = .01) were independent risk factors for increased hospital mortality. Preexisting diabetes mellitus was an independent risk factor for reduced hospital mortality (OR, 0.47; P = .04; test for interaction, P = .02). In indirect ARDS, only the number of organ failures was an independent predictor of mortality (OR, 2.08; P < .001).
CONCLUSIONS: Despite lower severity of illness and fewer organ failures, patients with direct ARDS had mortality rates similar to patients with indirect ARDS. Factors previously associated with mortality during ARDS were only associated with mortality in direct ARDS. These findings suggest that direct and indirect ARDS have distinct features that may differentially affect risk prediction and clinical outcomes.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARDS; diabetes; direct lung injury; indirect lung injury; mortality

Mesh:

Substances:

Year:  2016        PMID: 27663180      PMCID: PMC5472517          DOI: 10.1016/j.chest.2016.09.004

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  73 in total

1.  The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation.

Authors:  Jesús Villar; Jesús Blanco; José Manuel Añón; Antonio Santos-Bouza; Lluís Blanch; Alfonso Ambrós; Francisco Gandía; Demetrio Carriedo; Fernando Mosteiro; Santiago Basaldúa; Rosa Lidia Fernández; Robert M Kacmarek
Journal:  Intensive Care Med       Date:  2011-10-14       Impact factor: 17.440

2.  Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS.

Authors:  Chau-Chyun Sheu; Michelle N Gong; Rihong Zhai; Feng Chen; Ednan K Bajwa; Peter F Clardy; Diana C Gallagher; B Taylor Thompson; David C Christiani
Journal:  Chest       Date:  2010-05-27       Impact factor: 9.410

Review 3.  Pulmonary and extrapulmonary acute respiratory distress syndrome: are they different?

Authors:  Patricia R M Rocco; Walter A Zin
Journal:  Curr Opin Crit Care       Date:  2005-02       Impact factor: 3.687

4.  Comparison of hospital mortality and long-term survival in patients with acute lung injury/ARDS vs cardiogenic pulmonary edema.

Authors:  Christopher N Schmickl; Michelle Biehl; Gregory A Wilson; Ognjen Gajic
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

5.  Cigarette Smoke Exposure and the Acute Respiratory Distress Syndrome.

Authors:  Carolyn S Calfee; Michael A Matthay; Kirsten N Kangelaris; Edward D Siew; David R Janz; Gordon R Bernard; Addison K May; Peyton Jacob; Christopher Havel; Neal L Benowitz; Lorraine B Ware
Journal:  Crit Care Med       Date:  2015-09       Impact factor: 7.598

6.  Determinants of mortality in patients with severe sepsis.

Authors:  Joseph A Johnston
Journal:  Med Decis Making       Date:  2005 Jul-Aug       Impact factor: 2.583

Review 7.  Diabetes, insulin, and development of acute lung injury.

Authors:  Shyoko Honiden; Michelle N Gong
Journal:  Crit Care Med       Date:  2009-08       Impact factor: 7.598

8.  Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS.

Authors:  Michelle Ng Gong; Zhou Wei; Li-Lian Xu; David P Miller; B Taylor Thompson; David C Christiani
Journal:  Chest       Date:  2004-01       Impact factor: 9.410

9.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

10.  Prognostic factors in the acute respiratory distress syndrome.

Authors:  Wei Chen; Lorraine B Ware
Journal:  Clin Transl Med       Date:  2015-07-02
View more
  50 in total

Review 1.  Phenotypes in acute respiratory distress syndrome: moving towards precision medicine.

Authors:  Pratik Sinha; Carolyn S Calfee
Journal:  Curr Opin Crit Care       Date:  2019-02       Impact factor: 3.687

2.  Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: multicenter observational study in fifteen Italian ICUs.

Authors:  Lorenzo Gamberini; Tommaso Tonetti; Savino Spadaro; Gianluca Zani; Carlo Alberto Mazzoli; Chiara Capozzi; Emanuela Giampalma; Maria Letizia Bacchi Reggiani; Elisabetta Bertellini; Andrea Castelli; Irene Cavalli; Davide Colombo; Federico Crimaldi; Federica Damiani; Alberto Fogagnolo; Maurizio Fusari; Emiliano Gamberini; Giovanni Gordini; Cristiana Laici; Maria Concetta Lanza; Mirco Leo; Andrea Marudi; Giuseppe Nardi; Irene Ottaviani; Raffaella Papa; Antonella Potalivo; Emanuele Russo; Stefania Taddei; Carlo Alberto Volta; V Marco Ranieri
Journal:  J Intensive Care       Date:  2020-10-15

3.  Oxygenation Saturation Index Predicts Clinical Outcomes in ARDS.

Authors:  Katherine DesPrez; J Brennan McNeil; Chunxue Wang; Julie A Bastarache; Ciara M Shaver; Lorraine B Ware
Journal:  Chest       Date:  2017-08-16       Impact factor: 9.410

4.  Novel Method for Noninvasive Sampling of the Distal Airspace in Acute Respiratory Distress Syndrome.

Authors:  J Brennan McNeil; Ciara M Shaver; V Eric Kerchberger; Derek W Russell; Brandon S Grove; Melissa A Warren; Nancy E Wickersham; Lorraine B Ware; W Hayes McDonald; Julie A Bastarache
Journal:  Am J Respir Crit Care Med       Date:  2018-04-15       Impact factor: 21.405

5.  Subtypes of pediatric acute respiratory distress syndrome have different predictors of mortality.

Authors:  Nadir Yehya; Garrett Keim; Neal J Thomas
Journal:  Intensive Care Med       Date:  2018-07-03       Impact factor: 17.440

6.  Effect of ARDS Severity and Etiology on Short-Term Outcomes.

Authors:  Haitham El-Haddad; Hyejeong Jang; Wei Chen; Ayman O Soubani
Journal:  Respir Care       Date:  2017-05-30       Impact factor: 2.258

Review 7.  Cell therapy for the treatment of sepsis and acute respiratory distress syndrome.

Authors:  Raquel Guillamat-Prats; Marta Camprubí-Rimblas; Josep Bringué; Neus Tantinyà; Antonio Artigas
Journal:  Ann Transl Med       Date:  2017-11

8.  Alveolar Macrophage Transcriptional Programs Are Associated with Outcomes in Acute Respiratory Distress Syndrome.

Authors:  Eric D Morrell; Pavan K Bhatraju; Carmen R Mikacenic; Frank Radella; Anne M Manicone; Renee D Stapleton; Mark M Wurfel; Sina A Gharib
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

9.  Evidence of Endotypes in Pediatric Acute Hypoxemic Respiratory Failure Caused by Sepsis.

Authors:  Nadir Yehya; Neal J Thomas; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2019-02       Impact factor: 3.624

10.  Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe E. coli pneumonia.

Authors:  Jeonghyun Park; Seonguk Kim; Hyungsun Lim; Airan Liu; Shuling Hu; JaeHoon Lee; Hanjing Zhuo; Qi Hao; Michael A Matthay; Jae-W Lee
Journal:  Thorax       Date:  2018-08-03       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.